about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (...
Read More
752.8K
XNAS Volume
High vol.+gain this week
XNAS 09 May, 2025 9:56 AM (EDT)
Board Meeting
The board meeting for CorMedix Inc is scheduled for today, for the purpose of Cormedix Inc First Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..